HC Wainwright Raises Compass Therapeutics (NASDAQ:CMPX) Price Target to $24.00
Compass Therapeutics (NASDAQ:CMPX – Get Free Report) had its price objective upped by equities researchers at HC Wainwright from $10.00 to $24.00 in a research report issued on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Several other brokerages have also issued reports on CMPX. Leerink Partners upgraded shares of Compass […]
Compass Therapeutics (NASDAQ:CMPX – Get Free Report) had its price objective upped by equities researchers at HC Wainwright from $10.00 to $24.00 in a research report issued on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Several other brokerages have also issued reports on CMPX. Leerink Partners upgraded shares of Compass […]
